Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Treatment Of Neurofibroma In India"

15:20 EDT 24th July 2014 | BioPortfolio

Matching Channels

India

India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps...

India ink colloidal carbon stain

Pediculosis - louse (lice) treatment

   To view our most recent articles on Lice Treatment please go to: http://www.bioportfolio.com/news/article/987636/Pediculosis-Louse-Lice-Treatment.html    

Dysrhythmia Treatment

Treatment of Pain

Matching News

India/USA trade dispute could impact AIDS treatment programs

The trade dispute over intellectual property rights between the USA and India is set to derail the distribution of generic drugs, leaving millions of people without access to life saving medications,...

Pittsburgh cancer treatment company in $120M deal to expand in India

A Pittsburgh-based operator of cancer centers is expanding in India after signing a deal with General Electric Co.'s health care unit. Cancer Treatment Services International, which in 2012 built a...

Exclusive: Merck In Multiple Partnerships To Finance Hep C Treatment In India

In what could perhaps be the first such experiment in the Indian pharmaceutical industry, Merck’s Indian arm MSD India has linked up with a financial institution and is considering a national rollou...

India’s generics industry hires consultant to boost image

Companies specializing in generic pharmaceuticals in India and the U.S. have retained India First Group to promote the benefits of affordable access to medicine as vital to improving healthcare worldw...

India Pharma Delegation In Washington To Defend IP Practices

A delegation of India drug makers flew to Washington, D.C., to press the industry's case in U.S. trade investigations involving treatment of intellectual property, such as compulsory licenses for phar...

Roche Sues India Drug Regulator, Two Firms For Fate Of Its Herceptin

Roche's India subsidiary has filed a suit in India not only against two drug makers, Biocon and Mylan, but also the Drug Controller General of India over the launch of the first biosimilar of its Herc...

BIO Provides Recommendations for Growing India’s Biotech Industry

BIO and the Association of Biotechnology Led Enterprises (ABLE) released a new report today, entitled Accelerating Growth: Forging India’s Bioeconomy, which present recommendations in support the gr...

China and India face huge cancer burden: experts

China and India are facing a cancer crisis, with smoking, belated diagnosis and unequal access to treatment all causing large-scale problems, experts said on Friday.

Matching PubMed Articles

Neurofibroma of the palate.

Neurofibroma is a benign peripheral nerve sheath tumor comprising variable mixture of Schwann cells, perineurial-like cells, and fibroblasts. Neurofibroma may occur as solitary lesion or as part of a...

A Rare Solitary Neurofibroma of the Frontal Sinus.

Neurofibromas are common peripheral nerve sheath tumors related to Schwann cell's proliferation and are usually associated with neurofibromatosis type 1. Although solitary neurofibroma that occurs in...

Geniculo-temporo-parotideal neurofibroma of the facial nerve. A case report.

Preoperative diagnosis of facial nerve neurofibroma is difficult when it presents as an asymptomatic parotideal mass. Facial nerve tumor suspicion arises during parotid surgery, histopathologic evalua...

Isolated plexiform neurofibroma of the tongue.

Neurofibromas (NF) are benign tumors of neural origin, of which roughly 90% appear as solitary lesions. They are classified into cutaneous, subcutaneous, and plexiform subtypes. Plexiform neurofibroma...

A multicentre retrospective study to understand anti-platelet treatment patterns and outcomes of acute coronary syndrome patients in India (TRACE).

There is limited available information for treatment of acute coronary syndrome (ACS) with respect to outcomes, therapeutic agents and treatment practices. Our retrospective registry study collected a...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement